The complaint filed against the NYSE-listed firm alleges violations of the Securities Exchange Act, specifically targeting misleading public statements regarding the company's financial health. According to the litigation, SES AI overstated its performance by improperly trading access to its proprietary Molecular Universe platform in exchange for various vendor services. These actions, the lawsuit claims, left shareholders with a distorted view of the company’s actual market standing throughout the designated class period.

Those seeking to participate in the litigation must act before the June 26, 2026, deadline. While the DJS Law Group is actively soliciting investors to serve as lead plaintiffs, the firm notes that such an appointment is not a prerequisite for individual investors to pursue a recovery. Shareholders affected by the drop in stock value are encouraged to contact David J. Schwartz at the firm’s Eastchester office to discuss their legal standing and potential participation in the case.